Effect of triglitazone on the secretion of vascular active factors from endothelial cells stimulated by AngⅡ

Li Yongqin,Niu Xiaolin,Wang Congxia,Wei Jin,Wang Shijie,Zhou Juan
DOI: https://doi.org/10.3969/j.issn.1671-8259.2006.06.005
2006-01-01
Abstract:Objective To investigate the effect of PPAR γ ligand triglitazone on the secretion of ET-1and NO from endothelial cells stimulated by AngⅡ.Methods The cultured human umbilical vein endothelial cells(HUVECs) were treated with AngⅡand triglitazone.Chemiluminescence analysis was used to measure the concentration of NO,and radioimmunoassay method was used to detect the production of ET-1.Results The HUVECs were treated with 10μmol/L and 50μmol/L triglitazone.The concentration of ET-1 in cell culture supernatants decreased without statistical significance.The concentration of NO increased significantly compared with that of the control(P<0.05).50μmol/L triglitazone inhibited the production of AngⅡ(1×10~(-6)mol/L)-induced ET-1 obviously(P<0.05),and both 10μmol/L and 50μmol/L triglitazone could inhibit the effect of AngⅡ,which decreased NO release from the endothelial cells,indicating that the concentration of NO increased obviously(P<0.05).Conclusion Triglitazone can inhibit the effect of AngⅡ on endothelial cells,which enhances the production of ET-1 but decreases the synthesis and release of NO,showing that triglitazone has relation with the modulation of blood pressure.
What problem does this paper attempt to address?